» Articles » PMID: 17140099

[How to Define the Species Barrier to Pathogen Transmission?]

Overview
Specialty General Medicine
Date 2006 Dec 5
PMID 17140099
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A given microbial pathogen usually targets a restricted number of animal species. Some pathogens can be transmitted to humans from another animal species, either directly (rabies, brucellosis, etc.) or through a vector (Lyme's disease, West Nile fever, etc.). Few infectious agents with animal reservoirs infect humans, and even fewer are capable of human-human transmission. This is attributed to the "species barrier", a simplistic concept that in fact involves a series of conditions for successful inter-species transmission. These include access to an infectable surface, multiplication on that surface, colonisation, invasion, multiplication inside the new host, and resistance to innate and adaptive immune mechanisms. Each of these steps requires a specific ligand-receptor interaction. The full series of events must be "reprogrammed" for efficient implantation in a new host. These changes occur through mutations or genetic exchanges. Direct human-to-human transmission often requires additional adaptive modifications.

Citing Articles

Emerging Animal-Associated Fungal Diseases.

Carpouron J, de Hoog S, Gentekaki E, Hyde K J Fungi (Basel). 2022; 8(6).

PMID: 35736094 PMC: 9225262. DOI: 10.3390/jof8060611.


Cross species influenza: emerging zoonosis.

Wiwanitkit V Asian Pac J Trop Dis. 2020; 4:S642-S643.

PMID: 32289027 PMC: 7128874. DOI: 10.1016/S2222-1808(14)60696-4.


H7N9 Influenza: The Emerging Infectious Disease.

Wiwanitkit V N Am J Med Sci. 2013; 5(7):395-8.

PMID: 24020046 PMC: 3759064. DOI: 10.4103/1947-2714.115764.


H7N9 influenza-the laboratory presentations: a letter to editor.

Wiwanitkit V Asian Pac J Trop Biomed. 2013; 3(7):584-5.

PMID: 23835531 PMC: 3695587. DOI: 10.1016/S2221-1691(13)60118-5.

References
1.
Browning J, Horner J, Pettoello-Mantovani M, Raker C, Yurasov S, DePinho R . Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc Natl Acad Sci U S A. 1998; 94(26):14637-41. PMC: 25078. DOI: 10.1073/pnas.94.26.14637. View

2.
Alkhatib G, Combadiere C, Broder C, Feng Y, Kennedy P, Murphy P . CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996; 272(5270):1955-8. DOI: 10.1126/science.272.5270.1955. View

3.
Engelthaler D, Mosley D, Cheek J, Levy C, Komatsu K, Ettestad P . Climatic and environmental patterns associated with hantavirus pulmonary syndrome, Four Corners region, United States. Emerg Infect Dis. 1999; 5(1):87-94. PMC: 2627709. DOI: 10.3201/eid0501.990110. View

4.
Ohka S, Nomoto A . Recent insights into poliovirus pathogenesis. Trends Microbiol. 2001; 9(10):501-6. DOI: 10.1016/s0966-842x(01)02200-4. View

5.
Lecuit M, Cossart P . Genetically-modified-animal models for human infections: the Listeria paradigm. Trends Mol Med. 2002; 8(11):537-42. DOI: 10.1016/s1471-4914(02)02413-9. View